ssris-and-other-antidepressants
- Jan 28, 2006
- Admin
More focus is needed on the risk of activation or stimulation as described in the new class of warnings from the Food and Drug Administration, including anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania and other unusual changes of behavior, worsening of depression and suicidal ideation.
recentregulatory.pbreggin.2006.pdf
